I think Pf_老虎社区_美港股上老虎

AcidIce
2021-12-21

I think Pfizer is going to CRASH down until USD$50 first before anything good can happen....!!

EU drug regulator: still unclear if COVID-19 shots need tweaking for Omicron

Dec 21 (Reuters) - The European Union's drug regulator is prepared for the possibility that COVID-19

EU drug regulator: still unclear if COVID-19 shots need tweaking for Omicron

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":691080564,"tweetId":"691080564","gmtCreate":1640097965893,"gmtModify":1640097966009,"author":{"id":3569382039983887,"idStr":"3569382039983887","authorId":3569382039983887,"authorIdStr":"3569382039983887","name":"AcidIce","avatar":"https://static.tigerbbs.com/25a5edd325094826cf6e8822874786ab","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>I think Pfizer is going to CRASH down until USD$50 first before anything good can happen....!!</p></body></html>","htmlText":"<html><head></head><body><p>I think Pfizer is going to CRASH down until USD$50 first before anything good can happen....!!</p></body></html>","text":"I think Pfizer is going to CRASH down until USD$50 first before anything good can happen....!!","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/691080564","repostId":2193152135,"repostType":2,"repost":{"id":"2193152135","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640093300,"share":"https://www.laohu8.com/m/news/2193152135?lang=&edition=full","pubTime":"2021-12-21 21:28","market":"us","language":"en","title":"EU drug regulator: still unclear if COVID-19 shots need tweaking for Omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=2193152135","media":"Reuters","summary":"Dec 21 (Reuters) - The European Union's drug regulator is prepared for the possibility that COVID-19","content":"<p>Dec 21 (Reuters) - The European Union's drug regulator is prepared for the possibility that COVID-19 vaccines may be tweaked to fight the new Omicron variant although there is no evidence yet that it will be necessary, the agency's chief said on Tuesday.</p>\n<p>\"There is no answer whether we will need to adapt vaccines,\" European Medicines Agency's (EMA) executive director Emer Cook said in a media briefing.</p>\n<p>She said the agency needs more data on vaccine efficacy, the variant's transmissibility and the severity of disease it causes.</p>\n<p>Cook said did not think the world would still be in a pandemic a year ago when the agency gave the regulatory greenlight for the vaccine developed by Pfizer -BioNTech, the first in the region.</p>\n<p>The European Union has the capacity to make 300 million doses of vaccines per month as drugmakers have ramped up output to meet growing demand for its 450 million population, she said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU drug regulator: still unclear if COVID-19 shots need tweaking for Omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU drug regulator: still unclear if COVID-19 shots need tweaking for Omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-21 21:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 21 (Reuters) - The European Union's drug regulator is prepared for the possibility that COVID-19 vaccines may be tweaked to fight the new Omicron variant although there is no evidence yet that it will be necessary, the agency's chief said on Tuesday.</p>\n<p>\"There is no answer whether we will need to adapt vaccines,\" European Medicines Agency's (EMA) executive director Emer Cook said in a media briefing.</p>\n<p>She said the agency needs more data on vaccine efficacy, the variant's transmissibility and the severity of disease it causes.</p>\n<p>Cook said did not think the world would still be in a pandemic a year ago when the agency gave the regulatory greenlight for the vaccine developed by Pfizer -BioNTech, the first in the region.</p>\n<p>The European Union has the capacity to make 300 million doses of vaccines per month as drugmakers have ramped up output to meet growing demand for its 450 million population, she said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193152135","content_text":"Dec 21 (Reuters) - The European Union's drug regulator is prepared for the possibility that COVID-19 vaccines may be tweaked to fight the new Omicron variant although there is no evidence yet that it will be necessary, the agency's chief said on Tuesday.\n\"There is no answer whether we will need to adapt vaccines,\" European Medicines Agency's (EMA) executive director Emer Cook said in a media briefing.\nShe said the agency needs more data on vaccine efficacy, the variant's transmissibility and the severity of disease it causes.\nCook said did not think the world would still be in a pandemic a year ago when the agency gave the regulatory greenlight for the vaccine developed by Pfizer -BioNTech, the first in the region.\nThe European Union has the capacity to make 300 million doses of vaccines per month as drugmakers have ramped up output to meet growing demand for its 450 million population, she said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1201,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":79,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}